SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-14-020715
Filing Date
2014-11-14
Accepted
2014-11-14 06:02:52
Documents
4
Period of Report
2014-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K insy20141113_8k.htm 8-K 26068
2 EXHIBIT 99.1 ex99-1.htm EX-99 322996
3 EXHIBIT 99.2 ex99-2.htm EX-99 134614
4 ex99-1img001.gif GRAPHIC 4028
  Complete submission text file 0001437749-14-020715.txt   490492
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 141220239
SIC: 2834 Pharmaceutical Preparations